[Retracted] Cost-Effectiveness Analysis of Standardized Clinical Nutrition Diagnosis and Treatment Pathway in Patients with Pulmonary Infection

Table 5

Cost-effectiveness ratio and incremental cost-effectiveness ratio of total hospitalization expenses (ten thousand yuan) between each group.

Groups	Cost	Effect (%)		CER		Incremental cost	ICER
		Plasma albumin	Nonreadmission	Plasma albumin	Nonreadmission		Plasma albumin	Nonreadmission
T1	703.86	74	96	9.51	7.33	467.48	17.98	11.13
T2	23.64	48	54	49.24	4.38
C1	915.46	66	86	13.875	10.64	629.15	26.21	78.64
C2	286.31	42	78	6.82	3.67
T1	644.13	68	88	9.47	7.32	-271.33	-135.67	-135.67
C1	915.46	66	86	13.87	13.87